Marcelo Henrique dos Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marcelo Henrique dos Santos has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo dos Reis
Barretos Cancer Hospital, Department of Gynecologic Oncology, Barretos, Brazil
4 shared publications - Adhemar Longatto-Filho
Medical Laboratory of Medical Investigation (LIM/14), Department of Pathology São Paulo University Faculty of Medicine São Paulo Brazil
2 shared publications - Ana Carla Franco Ubinha
Department of Gynecologic Oncology, Barretos Cancer Hospital, Barretos 14784-400, Brazil
2 shared publications - Agnaldo Lopes da Silva Filho
Universidade Federal de Minas Gerais Belo Horizonte MG Brazil Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
1 shared publication - Aline Cássia Tadini
Barretos School of Health Sciences, Dr. Paulo Prata-FACISB, Barretos 14785-002, Brazil
1 shared publication - Andressa Melina Severino Teixeira
Gynecology and Obstetrics Department, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brazil
1 shared publication
Latest Publications
- 6 October 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (10)
Radical trachelectomy in Brazil: a multi-institutional review on fertility preservation and oncologic outcomes
- 6 October 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (10)
Radical trachelectomy in Brazil: a multi-institutional review on fertility preservation and oncologic outcomes
- Open Access
The Impact of the Number of Neoadjuvant Chemotherapy Cycles on Outcomes in Advanced Ovarian Cancer: A Narrative Review
Although standard chemotherapy for three to four cycles followed by surgery is considered safe and effective in the management of advanced ovarian cancer, the impact of extending treatment beyond this period remains uncertain. Some authors suggest that the number of neoadjuvant chemotherapy cycles does not directly affect prognosis and may reflect a confounding bias. Others, however, indicate that a prolonged exposure to chemotherapy can promote the selection of resistant tumor clones, negatively influencing patient survival and disease progression. This review aims to summarize the current evidence on the topic, evaluating the effect of prolonged chemotherapy on surgical cytoreduction and survival. To achieve this, we conducted an analysis of the English-language literature available in PubMed, focusing on treatment duration, achievement of complete surgical resection, survival outcomes, and prognostic factors.
Open AccessThe Impact of the Number of Neoadjuvant Chemotherapy Cycles on Outcomes in Advanced Ovarian Cancer: A Narrative Review
Although standard chemotherapy for three to four cycles followed by surgery is considered safe and effective in the management of advanced ovarian cancer, the impact of extending treatment beyond this period remains uncertain. Some authors suggest that the number of neoadjuvant chemotherapy cycles does not directly affect prognosis and may reflect a confounding bias. Others, however, indicate that a prolonged exposure to chemotherapy can promote the selection of resistant tumor clones, negatively influencing patient survival and disease progression. This review aims to summarize the current evidence on the topic, evaluating the effect of prolonged chemotherapy on surgical cytoreduction and survival. To achieve this, we conducted an analysis of the English-language literature available in PubMed, focusing on treatment duration, achievement of complete surgical resection, survival outcomes, and prognostic factors.
- Open Access
The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature
Pelvic exenteration represents a radical procedure aimed at achieving complete tumor resection with negative margins. Although it is the only therapeutic option for some cases of advanced tumors, it is associated with several perioperative complications. We believe that careful patient selection is related to better oncologic outcomes and lower complication rates. The objectives of this review are to identify the most current indications for this intervention, suggest criteria for case selection, evaluate recommendations for perioperative care, and review oncologic outcomes and potential associated complications. To this end, an analysis of English language articles in PubMed was performed, searching for topics such as the indication for pelvic exenteration for recurrent gynecologic neoplasms selection of oncologic cases, the impact of tumor size and extent on oncologic outcomes, preoperative and postoperative surgical management, surgical complications, and outcomes of overall survival and recurrence-free survival.
Open AccessThe Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature
Pelvic exenteration represents a radical procedure aimed at achieving complete tumor resection with negative margins. Although it is the only therapeutic option for some cases of advanced tumors, it is associated with several perioperative complications. We believe that careful patient selection is related to better oncologic outcomes and lower complication rates. The objectives of this review are to identify the most current indications for this intervention, suggest criteria for case selection, evaluate recommendations for perioperative care, and review oncologic outcomes and potential associated complications. To this end, an analysis of English language articles in PubMed was performed, searching for topics such as the indication for pelvic exenteration for recurrent gynecologic neoplasms selection of oncologic cases, the impact of tumor size and extent on oncologic outcomes, preoperative and postoperative surgical management, surgical complications, and outcomes of overall survival and recurrence-free survival.
- Open Access
- 22 September 2023
- Published by Elsevier in Gynecologic Oncology
- Vol. 176, S86
Cervical cancer in young women: Are there differences in demographic, histologic factors and clinical characteristics? (1114)
- 22 September 2023
- Published by Elsevier in Gynecologic Oncology
- Vol. 176, S86
Open AccessCervical cancer in young women: Are there differences in demographic, histologic factors and clinical characteristics? (1114)